ÂÜÀòÂÒÂ×

Hiroto Kambara, Ph.D. has extensive work experience in various scientific roles. Hiroto is currently working as a Principal Scientist at Matchpoint Therapeutics since June 2021. Prior to this, they served as a Consultant at Atlas Venture NewCo from April to May 2021.

From September 2019 to March 2021, Hiroto held the position of Principal Scientist at Quench Bio. Additionally, they briefly worked as a Senior Scientist at Quench Bio from June to September 2019.

Hiroto's previous experience includes working at Harvard Medical School as an Instructor from July 2018 to June 2019. During their time there, they led multiple research projects on infectious and inflammatory diseases, prepared manuscripts for publications and grant applications.

Hiroto also held the role of Research Fellow at Harvard Medical School from October 2014 to June 2018. In this role, Hiroto was responsible for establishing a high-throughput screening system for drug discovery and identifying initial candidates for inflammatory diseases. Hiroto also assisted with ELISA and hybridoma screening, used various techniques such as molecular biology, cell biology, tissue culture, viral production/transduction, flow cytometry, imaging techniques, and mouse models extensively.

Prior to their time at Harvard Medical School, Hiroto worked as an Instructor and Research Fellow at Boston Children's Hospital from July 2018 to June 2019 and from October 2014 to June 2018, respectively.

Hiroto's work experience also includes a Research Fellow role at Case Western Reserve University from September 2012 to August 2014. Hiroto used RNA-seq with next-generation sequencing (NGS), Genome browser, and RT-qPCR to identify functional long non-coding RNAs induced by Interferon-α in primary human hepatocyte. Hiroto also presented scientific data at conferences and published two scientific papers.

Furthermore, Hiroto served as a Research Assistant Professor at Osaka University from April 2011 to August 2012. During this time, they identified and analyzed host factors critical for viral replication and pathogenesis. Hiroto mentored and trained graduate students, prepared and presented class lectures in microbiology, and published seven scientific papers.

Overall, Hiroto Kambara, Ph.D. has a diverse work experience in various scientific roles, with a strong focus on infectious and inflammatory diseases, drug discovery, and molecular biology techniques.

Hiroto Kambara, Ph.D. obtained a Bachelor's and Master's degree in Pharmacy from Kobe Gakuin University, where they studied from 2000 to 2006. In 2007, they enrolled at Osaka University, pursuing a Doctor of Philosophy (Ph.D.) degree in Virology, which they successfully completed in 2011.